Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vascular function: a key player in hypertension.
Tomiyama H. Tomiyama H. Hypertens Res. 2023 Sep;46(9):2145-2158. doi: 10.1038/s41440-023-01354-3. Epub 2023 Jun 27. Hypertens Res. 2023. PMID: 37369849 Review.
An evidence review project for food with function claims ~Challenges of the Japan society for vascular failure for the promotion of adequate evidences for food with function claims.
Matsumoto C, Tomiyama H, Takahashi O, Maruhashi T, Matsuzawa Y, Masaki N, Muraki I, Yano Y, Sugimoto T, Kabutoya T, Sawami K, Tanaka A, Arima H, Sata M, Node K. Matsumoto C, et al. Among authors: tomiyama h. Hypertens Res. 2024 Feb;47(2):533-536. doi: 10.1038/s41440-023-01485-7. Epub 2023 Oct 31. Hypertens Res. 2024. PMID: 37907601 No abstract available.
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding Study.
Miwa Y, Mutoh A, Morimoto T, Ikehara Y, Yasu T, Koba S, Ako J, Higashi Y, Kajikawa M, Uehara H, Ishikawa K, Sakuma I, Tomiyama H, Node K, Kumagai Y, Ueda S. Miwa Y, et al. Among authors: tomiyama h. Biomed Hub. 2022 Dec 5;7(3):156-164. doi: 10.1159/000527411. eCollection 2022 Sep-Dec. Biomed Hub. 2022. PMID: 36643381 Free PMC article.
Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes.
Iijima Y, Nakayama M, Miwa T, Yakou F, Tomiyama H, Shikuma J, Ito R, Tanaka A, Manda N, Odawara M. Iijima Y, et al. Among authors: tomiyama h. Intern Med. 2023;62(5):681-688. doi: 10.2169/internalmedicine.6685-20. Epub 2023 Mar 1. Intern Med. 2023. PMID: 36858619 Free PMC article.
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial.
Tanaka A, Shimabukuro M, Teragawa H, Yoshida H, Okada Y, Takamura T, Taguchi I, Toyoda S, Tomiyama H, Ueda S, Higashi Y, Node K; EMBLEM Investigators. Tanaka A, et al. Among authors: tomiyama h. Hypertens Res. 2024 May 24. doi: 10.1038/s41440-024-01725-4. Online ahead of print. Hypertens Res. 2024. PMID: 38789538
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML; Collaborative Group for Studies of Yellow Fever Vaccine; Martins-Filho OA, do Antonelli LRDV. Abdala-Torres T, et al. Among authors: tomiyama hti. NPJ Vaccines. 2024 Mar 8;9(1):54. doi: 10.1038/s41541-024-00836-w. NPJ Vaccines. 2024. PMID: 38459059 Free PMC article.
495 results